{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:07:39Z","timestamp":1747181259698,"version":"3.40.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:p>Yinxing Mihuan Oral Solution (YMOS) is a Chinese patent medicine for treating coronary heart disease combined anxiety (CHDCA), but the molecular mechanism of its treatment is still unclear. This article aims to understand the molecular mechanism, optimize clinical drug use, and guide new drug development. Using the Swiss Target Prediction database, we obtained the main chemical composition of YMOS. Then we used network pharmacology to identify their potential targets. Network construction, coupled with protein\u2013protein interaction and enrichment analysis was used to identify representative components and core targets. Finally, molecular docking simulation was conducted to further refine the drug\u2013target interaction. Forty-two active chemicals were found in YMOS and 91 target genes related to CHDCA. The treatment effect was found to be associated with 1908 biological processes and 160 pathways, as revealed by the outcomes of the enrichment analysis. The potential therapeutic mechanisms of the drug are closely related to its antioxidant, anti-inflammatory, and vascular function regulation pathways, and the main core targets include albumin, tumor necrosis factor, TP53, AKT serine\/threonine kinase 1, interleukin 1 beta, and vascular endothelial growth factor A. The potential molecular mechanisms of YMOS in CHDCA treatment were identified using network pharmacology and molecular docking approaches. The results reveal the systemic biological implications of YMOS. This study has systematically uncovered the molecular mechanism of YMOS for the first time, offering fresh insights for evidence-based clinical applications.<\/jats:p>","DOI":"10.1097\/md.0000000000040183","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:01:43Z","timestamp":1730214103000},"page":"e40183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic mechanism and key active ingredients of Yinxing Mihuan Oral Solution in coronary heart disease comorbidity with anxiety: A network pharmacology and molecular docking approach"],"prefix":"10.1097","volume":"103","author":[{"given":"Jiajun","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaigang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China"},{"name":"Medical College of Nanchang University, Nanchang, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuncheng","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Science and Education, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4272-7473","authenticated-orcid":false,"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e21722","DOI":"10.1161\/JAHA.121.021722","article-title":"Anxiety disorders are associated with coronary endothelial dysfunction in women with chest pain and nonobstructive coronary artery disease.","volume":"10","author":"Sara","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.psym.2018.03.008","article-title":"Treatment of anxiety in patients with coronary heart disease: a systematic review.","volume":"59","author":"Farquhar","year":"2018","journal-title":"Psychosomatics"},{"key":"R3-20250504","first-page":"1","article-title":"Assessing anxiety and depression: a comparison of national health interview survey measures.","volume":"172","author":"Zablotsky","year":"2022","journal-title":"Natl Health Stat Report"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"669000","DOI":"10.3389\/fpsyg.2021.669000","article-title":"coronary heart disease and depression or anxiety: a bibliometric analysis.","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Psychol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1542\/peds.2020-1693","article-title":"Mental health disorders in children with congenital heart disease.","volume":"147","author":"Gonzalez","year":"2021","journal-title":"Pediatrics"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"695925","DOI":"10.1155\/2013\/695925","article-title":"Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.","volume":"2013","author":"Huffman","year":"2013","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e25084","DOI":"10.1097\/MD.0000000000025084","article-title":"Comparison of efficacy and safety of complementary and alternative therapies for coronary heart disease complicated with anxiety or depression disorder: a protocol for bayesian network meta-analysis.","volume":"100","author":"Han","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"854292","DOI":"10.3389\/fphar.2022.854292","article-title":"Evidence and characteristics of traditional chinese medicine for coronary heart disease patients with anxiety or depression: a meta-analysis and systematic review.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3389\/fphar.2019.00844","article-title":"Traditional chinese medicine for coronary heart disease: clinical evidence and possible mechanisms.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Pharmacol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional chinese medicine for cardiovascular disease: evidence and potential mechanisms.","volume":"69","author":"Hao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"5165075","DOI":"10.1155\/2021\/5165075","article-title":"Pharmacological mechanism of danggui-sini formula for intervertebral disc degeneration: a network pharmacology study.","volume":"2021","author":"Wang","year":"2021","journal-title":"Biomed Res Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1193846","DOI":"10.1155\/2022\/1193846","article-title":"Decoding the mechanism of cherecunjin formula in treating sjogren\u2019s syndrome based on network pharmacology and molecular docking.","volume":"2022","author":"Xu","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"105391","DOI":"10.1016\/j.archoralbio.2022.105391","article-title":"Exploring the pharmacological components and effective mechanism of mori folium against periodontitis using network pharmacology and molecular docking.","volume":"139","author":"Wu","year":"2022","journal-title":"Arch Oral Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"114937","DOI":"10.1016\/j.jpba.2022.114937","article-title":"The qualitative and quantitative profiling for quality assessment of yinxing mihuan oral solution and the stability study on the focused flavonol glycosides.","volume":"219","author":"Xue","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/nu13010273","article-title":"Polyphenols and human health: the role of bioavailability.","volume":"13","author":"Di Lorenzo","year":"2021","journal-title":"Nutrients"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1021\/jf304076z","article-title":"Antioxidant activity of phenolic acids and their metabolites: synthesis and antioxidant properties of the sulfate derivatives of ferulic and caffeic acids and of the acyl glucuronide of ferulic acid.","volume":"60","author":"Piazzon","year":"2012","journal-title":"J Agric Food Chem"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/nu11010107","article-title":"Identification of six phytochemical compounds from asparagus officinalis l. Root cultivars from new zealand and china using uae-spe-uplc-ms\/ms: effects of extracts on h (2)o(2)-induced oxidative stress.","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"726341","DOI":"10.3389\/fcvm.2021.726341","article-title":"Anti-inflammatory therapies for coronary heart disease: a systematic review and meta-analysis.","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.","volume":"20","author":"Forman","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pnpbp.2017.03.016","article-title":"The anti-inflammatory mechanism of antidepressants - ssris, snris.","volume":"80","author":"Galecki","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/hc4601.099485","article-title":"Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.","volume":"104","author":"Heitzer","year":"2001","journal-title":"Circulation"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"12897","DOI":"10.1038\/s41598-021-92421-7","article-title":"Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients.","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2013.02.003","article-title":"Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours.","volume":"37","author":"Moylan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1038\/emm.2014.69","article-title":"Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (ido1) by ido2.","volume":"46","author":"Lee","year":"2014","journal-title":"Exp Mol Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-protein-coupled receptors in heart disease.","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"R26-20250504","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis.","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol Sci"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/CIR.0000000000001039","article-title":"2021 acc\/aha\/scai guideline for coronary artery revascularization: executive summary: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines.","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the american heart association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-ht receptors.","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R30-20250504","first-page":"2326","article-title":"ASCVD risk stratification among cancer survivors.","volume":"77","author":"Das","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fcell.2020.00749","article-title":"The role of proteoglycans in cancer metastasis and circulating tumor cell analysis.","volume":"8","author":"Ahrens","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12872-024-03873-4","article-title":"Serum albumin and cardiovascular disease: a mendelian randomization study.","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"109207","DOI":"10.1016\/j.intimp.2022.109207","article-title":"Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis.","volume":"112","author":"Huang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.gendis.2019.03.002","article-title":"Association of a genetic variant in akt1 gene with features of the metabolic syndrome.","volume":"6","author":"Eshaghi","year":"2019","journal-title":"Genes Dis"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events.","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3324\/haematol.2022.280755","article-title":"Serum vascular endothelial growth factor is associated with cardiovascular involvement and response to therapy in Erdheim-Chester disease.","volume":"108","author":"Roeser","year":"2022","journal-title":"Haematologica"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:54:20Z","timestamp":1746320060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":36,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040183","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}